Humana’s profits shot up by 68% in the 2025 first quarter on higher revenues as the company continued to yield strong returns from its pharmacy, primary care and home solutions subsidiary, CenterWell.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

EPS estimates with $11.58, reaffirmed 2025 guidance, and outlined margin goals despite a drop in Medicare Advantage ...

Despite the outperformance, the payer’s stock was largely flat following the earnings release — a market reaction that ...

Key Takeaways Humana beat first-quarter profit and sales estimates as it reduced costs and exited some Medicare Advantage ...

Humana ( HUM) reported first quarter earnings that met Wall Street expectations Wednesday. The company beat on adjusted ...

Health insurer Humana on Wednesday reported lower-than expected medical costs in the first quarter, allaying investor ...

The health insurer reported an adjusted profit of $11.58 a share, beating expectations, as revenue rose about 8% from a year ...

Humana, the second-largest Medicare Advantage insurer with 5.8 million beneficiaries, reported Wednesday that net income ...

Discover insights from Humana's Q1 2025 earnings call: growth in Medicaid, strategic investments in CenterWell, and reaffirmed $16.25 EPS guidance.

Q1 2025 - Earnings Conference Call April 30, 2025 8:00 AM ETCompany ParticipantsLisa Stoner - VP, IRJames Rechtin - President, ...

While Humana affirmed its full-year profit outlook, which can be viewed as a positive in the current uncertain economic ...